Though there is a good theoretical basis for the use of
arimidex on endometriosis, I believe that this is still an off-label indication for the drug
and the clinical basis for its use is still from phase II clinical trials (studies with still low number of patients). Until such time that the indication of endometriosis can be demonstrated in large phase III clinical trials, the use of arimidex for endometriosis is still controversial.